Caplight Directory>Companies>RNATICS-preview>Rnatics


RNATICS

RNATICS

Private
GermanyN/Ahttps://rnatics.com/

Last Round

Grant

Feb 20, 2026

Total Funding Raised

$11.1M

Company Overview

RNATICS is a drug discovery company that develops RNA-based therapeutic methods intended for the treatment of severe diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RNATICS Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RNATICS Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 20, 2026
AcceleratorJun 26, 2024
GrantJan 13, 2022
SpinoffJan 1, 2021
View all Funding Rounds

RNATICS Investors

Notable investors and investment history

InvestorRounds
Technical University of MunichSpinoff
Munich Accelerator Life Sciences & MedicineAccelerator
BioM AG Munich BioTech DevelopmentAccelerator
Federal Ministry of Research, Technology and SpaceGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2026

    $3.18M grant from the Federal Ministry of Research, Technology and Space.

  • May 1, 2025

    Monthly visitors increased 45% MoM.

View all signals

RNATICS Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RNATICS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RNATICS's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany
Employee Range5
Year Founded2021
Last FundingFeb 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.